Daily non-political popular news in brief.

Value of stent-coating drugs questioned

New research about possible additive drugs to help reduce the reclosing of an artery after a metal stent has been inserted to keep it open was presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit in New Orleans, La.

Read more »

Keywords: value, stent-coating, drugs, questioned, stent, coating, drug

« Previous | Next »

Similar news on "Value of stent-coating drugs questioned":

1. Use of increasingly popular treatment for wound healing questioned
   07-30-2007 · EurekAlert!
   The effectiveness and value of an increasingly popular treatment used in the treatment of long term wounds are questioned in this month’s Drug and Therapeutics Bulletin (DTB)Topical negative pressure, or VAC Therapy as it is sometimes known, involves first placing a foam dressing, cut to shape, into a wound.
   Similar news · Read more »
   
2. A 'micro pharmacy' inside
   02-11-2008 · Massachusetts Institute of Technology (MIT)
   A new thin-film coating developed at MIT can deliver controlled drug doses to specific targets in the body following implantation, essentially serving as a "micro pharmacy." The film could eventually be used to deliver drugs for many diseases.
   Similar news · Read more »
   
3. Bioabsorbable stent shows excellent performance
   03-24-2007 · EurekAlert!
   The use of slow-release drugs in stents (drug-eluting stents) has dramatically reduced restenosis rates after percutaneous coronary intervention. However, these permanent metal devices may impair coronary imaging, predispose patients to late stent thrombosis, prevent positive remodeling and hinder revascularization. A study presented today at the American College of Cardiology's Innovation in Intervention: i2Summit assesses the safety and performance of a bioabsorbable stent that, if effective, could eliminate several of the problems associated with metallic stents.
   Similar news · Read more »
   
4. Hopkins scientists uncover cause of antipsychotic drug weight gain
   02-12-2007 · EurekAlert!
   Johns Hopkins brain scientists have hit on how and why some powerful drugs used for treating mental illnesses cause patients to gain so much weight that they often develop life-threatening complications such as diabetes and heart disease.
   Similar news · Read more »
   
5. Studies highlight 'real world' use, safety of drug-eluting stents
   03-26-2007 · EurekAlert!
   Research presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit 2007 in New Orleans, La, paints a picture of the "real world" use of drug-eluting stents and offers new insight into the connection between blood clotting, or thrombosis, in the stent -- a dangerous complication -- and adherence and responsiveness to anti-clotting medication.
   Similar news · Read more »
   
6. Drug reps use friendship to influence doctors, says faculty member
   04-23-2007 · EurekAlert!
   In a unique collaborative paper in PLoS Medicine, Georgetown University Medical Center's Adriane Fugh-Berman, who studies drug marketing, and a former drug rep reveal the tactics used by drug reps to manipulate physicians into selling drugs.
   Similar news · Read more »
   
7. Drug company funding of drug trials greatly influences outcome
   06-04-2007 · EurekAlert!
   In head-to-head trials of two drugs, the one deemed better appears to depend largely on who is funding the study, according to an analysis of nearly 200 statin-drug comparisons carried out between 1999 and 2005.
   Similar news · Read more »
   
8. Other highlights in JNCI, June 26
   06-26-2007 · EurekAlert!
   Also in the June 26 JNCI are a study of sexual function in men taking a potential prostate cancer prevention drug, a review of the use surrogate endpoint in clinical cancer research, and a more efficient clinical trial design for testing targeted drugs.
   Similar news · Read more »
   
9. Latest drugs improve survival for metastatic breast cancer
   07-23-2007 · EurekAlert!
   Newer drug therapies available since the 1990s, in particular aromatase inhibitors, improve the survival of women with metastatic breast cancer in the general population, according to a new study.
   Similar news · Read more »
   
10. Drug-eluting stent controversy explored in the American Heart Hospital Journal
    08-08-2007 · EurekAlert!
    The Summer 2007 issue of the American Heart Hospital Journal explores one of the pivotal issues in cardiology today, the drug-eluting stent. Through commentaries from 10 leading national and international specialists, the issue presents a comprehensive discussion on the explosive growth and the potential risks of DESs.
    Similar news · Read more »